Literature DB >> 25263854

Prognostic evaluations of small size lung cancers by 18F-FDG PET/CT and thin-section CT.

Mariko Kishimoto1, Shingo Iwano2, Shinji Ito1, Katsuhiko Kato3, Rintaro Ito1, Shinji Naganawa1.   

Abstract

PURPOSE: Primary lung cancers have varying prognoses, even for tumors ≤3cm in diameter. Thus, a thorough evaluation is necessary for therapeutic planning. Two imaging biomarkers have been shown to be useful for predicting primary lung cancer prognosis: maximum standardized uptake values (SUVmax) on fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) and the consolidation/tumor (C/T) ratio defined as the maximum diameter of consolidation within a tumor to the maximum tumor diameter on thin-section computed tomography (TSCT). We compared these biomarkers for predicting post-surgical recurrence in patients with small lung cancers.
MATERIALS AND METHODS: Clinical records, post-operative pathologic findings, and pre-operative PET/CT and TSCT images were reviewed. Solitary primary lung cancers of ≤3cm in diameter after surgical resection were selected for analysis. SUVmax and C/T ratios were recorded. Kaplan-Meier survival curves and Cox hazards ratios were used to identify independent predictors of lung cancer recurrence from among age, gender, surgical procedure, lesion size, C/T ratio, and SUVmax.
RESULTS: A total of 169 patients (114 males and 55 females; age range: 34-87 years) with solitary lung cancers were evaluated. The median post-operative follow-up period was 42 months. Twenty-eight patients had cancer recurrence with significantly higher SUVmax (p<0.001) and C/T ratios (p<0.001) than patients without recurrence. Disease-free survival was significantly reduced for SUVmax of ≥2.5 vs. SUVmax of <2.5 (p<0.001) or for a C/T ratio of ≥50% vs. a C/T ratio of <50% (p=0.030). For 19 patients with C/T ratios of <50%, none had a post-operative recurrence. A Cox hazards ratio model showed that only SUVmax was an independent predictor of recurrence (hazards ratio=1.324; p<0.001).
CONCLUSION: SUVmax on FDG-PET/CT was a significant imaging biomarker relevant to the prognosis of patients with lung cancers, and was superior to the C/T ratio on TSCT for predicting postoperative recurrence, particularly for solid type lung cancer.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Computed tomography; Consolidation/tumor ratio; Imaging biomarker; Lung cancer; Non-small cell carcinoma; Positron emission tomography; Prognosis; SUVmax

Mesh:

Substances:

Year:  2014        PMID: 25263854     DOI: 10.1016/j.lungcan.2014.09.006

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  11 in total

1.  Evaluation of lung cancer by enhanced dual-energy CT: association between three-dimensional iodine concentration and tumour differentiation.

Authors:  Shingo Iwano; Rintaro Ito; Hiroyasu Umakoshi; Shinji Ito; Shinji Naganawa
Journal:  Br J Radiol       Date:  2015-09-02       Impact factor: 3.039

Review 2.  Present and future roles of FDG-PET/CT imaging in the management of lung cancer.

Authors:  Kazuhiro Kitajima; Hiroshi Doi; Tomonori Kanda; Tomohiko Yamane; Tetsuya Tsujikawa; Hayato Kaida; Yukihisa Tamaki; Kozo Kuribayashi
Journal:  Jpn J Radiol       Date:  2016-04-27       Impact factor: 2.374

3.  Feasibility of limited resection for peripheral small-sized non-small cell lung cancer: a retrospective single-center-based study.

Authors:  Masato Aragaki; Yasuhiro Hida; Tatsuya Kato; Aki Fujiwara-Kuroda; Kichizo Kaga; Satoru Wakasa
Journal:  J Cancer Res Clin Oncol       Date:  2020-11-05       Impact factor: 4.553

4.  Prediction of occult lymph node metastasis using volume-based PET parameters in small-sized peripheral non-small cell lung cancer.

Authors:  Seong Yong Park; Joon-Kee Yoon; Kwang Joo Park; Su Jin Lee
Journal:  Cancer Imaging       Date:  2015-12-22       Impact factor: 3.909

5.  Predictive value of 18F-FDG PET and CT morphologic features for recurrence in pathological stage IA non-small cell lung cancer.

Authors:  Kai-Hsiung Ko; Hsian-He Hsu; Tsai-Wang Huang; Hong-Wei Gao; Cheng-Yi Cheng; Yi-Chih Hsu; Wei-Chou Chang; Chi-Ming Chu; Jia-Hong Chen; Shih-Chun Lee
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

6.  Microscopic Invasions, Prognoses, and Recurrence Patterns of Stage I Adenocarcinomas Manifesting as Part-Solid Ground-Glass Nodules: Comparison With Adenocarcinomas Appearing as Solid Nodules After Matching Their Solid Parts' Size.

Authors:  Eui Jin Hwang; Chang Min Park; Young Tae Kim; Hyungjin Kim; Jin Mo Goo
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

Review 7.  [Progress of Postoperative Adjuvant Chemotherapy in Stage I Non-small Cell Lung Cancer].

Authors:  Bo Liu; Fengxia Ding; Shuangqiang Yang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2015-06

8.  Iodine-related attenuation in contrast-enhanced dual-energy computed tomography in small-sized solid-type lung cancers is associated with the postoperative prognosis.

Authors:  Shingo Iwano; Shinichiro Kamiya; Rintaro Ito; Shota Nakamura; Shinji Naganawa
Journal:  Cancer Imaging       Date:  2021-01-07       Impact factor: 3.909

9.  Evaluation of locoregional invasiveness of small-sized non-small cell lung cancers by enhanced dual-energy computed tomography.

Authors:  Hironori Shimamoto; Shingo Iwano; Hiroyasu Umakoshi; Koji Kawaguchi; Shinji Naganawa
Journal:  Cancer Imaging       Date:  2016-07-26       Impact factor: 3.909

10.  Preoperative identification of clinicopathological prognostic factors for relapse-free survival in clinical N1 non-small cell lung cancer: a retrospective single center-based study.

Authors:  Masato Aragaki; Tatsuya Kato; Aki Fujiwara-Kuroda; Yasuhiro Hida; Kichizo Kaga; Satoru Wakasa
Journal:  J Cardiothorac Surg       Date:  2020-08-28       Impact factor: 1.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.